Not checkedNot checked for notices yet.
Different hotspot p53 mutants exert distinct phenotypes and predict outcome of colorectal cancer patients
Ori Hassin, Nishanth Belugali Nataraj, Michal Shreberk-Shaked and 18 more
Nature Communications · 2022
doi:10.1038/s41467-022-30481-7 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
The differential effects of TP53 missense mutations in colorectal cancer (CRC) remain to be explored. Here the authors compare the gain of function impact of two frequent TP53 mutations in CRC and show that p53R273 mutants control a transcriptional program, which drives oncogenic signaling pathways, leading to a more aggressive phenotype and worse patient outcome.
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.